MedPath
NMPA Approval

Cetirizine Hydrochloride Tablets

国药准字HJ20171303

November 4, 2022

H20171303

Drug Information

盐酸西替利嗪片

仙特明

片剂

10mg

化学药品

November 4, 2022

November 3, 2027

Company Information

Applicant Company

UCB-Pharma SA

Chemin de Croix-Blanche 10, 1630 Bulle

Manufacturing Company

UCB Farchim SA

Z.I.de planchy, Chemin de Croix-Blanche 10, CH-1630 Bulle

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸西替利嗪片 - NMPA 批准文号 | MedPath